Pharmafile Logo
Pharmafocus logo
Advanced Search

dynavax

Showing 3 posts of 3 posts found.

dynavax

Hep-B vaccine four-year battle for FDA approval is finally won

November 10, 2017
Medical Communications, Sales and Marketing biotech, drugs, dynavax, hepatitis B, pharma, pharmaceutical

Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data …

News
dynavax

FDA to review investigational hepatitis B vaccine

April 1, 2016
Medical Communications, Research and Development dynavax, hepatitis B, vaccines

Dynavax Technologies (NASDAQ: DVAX) says the FDA has accepted for review the company’s investigational adult hepatitis B vaccine, HEPLISAV-B. The FDA has set …

News
Keytruda image

Merck tests new Keytruda combination

June 3, 2015
Research and Development, Sales and Marketing Merck, dynavax, keytruda

Merck is continuing to investigate Keytruda combinations as it signs a deal to test the drug with an immunotherapy from …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026